Neurogene (NGNE) Net Margin: 2019-2025

Historic Net Margin for Neurogene (NGNE) over the last 3 years, with Sep 2025 value amounting to 50,240.48%.

  • Neurogene's Net Margin fell 5690163.00% to 50,240.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 14,225.74%, marking a year-over-year increase of 824632.00%. This contributed to the annual value of -8,184.43% for FY2024, which is 19625586.00% down from last year.
  • Per Neurogene's latest filing, its Net Margin stood at 50,240.48% for Q3 2025, which was up 60.06% from 31,387.84% recorded in Q2 2025.
  • In the past 5 years, Neurogene's Net Margin registered a high of 408,700.00% during Q1 2023, and its lowest value of 2,834.05% during Q1 2024.
  • Over the past 3 years, Neurogene's median Net Margin value was 50,240.48% (recorded in 2025), while the average stood at 125,450.89%.
  • In the last 5 years, Neurogene's Net Margin crashed by 40,586,595bps in 2024 and then skyrocketed by 2,789,215bps in 2025.
  • Neurogene's Net Margin (Quarterly) stood at 82,170.59% in 2023, then plummeted by 7,742,276bps to 4,747.83% in 2024, then slumped by 5,690,163bps to 50,240.48% in 2025.
  • Its Net Margin was 50,240.48% in Q3 2025, compared to 31,387.84% in Q2 2025 and 28,491.25% in Q1 2025.